Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
OrbusNeich® Announces Japan Approval for COMBO® Plus Coronary Stent 2019-09-26 01:01
Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications 2019-09-25 18:44
Launch of the Penlon Sigma EVA Vaporizer for Desflurane 2019-09-25 17:00
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA's approval of the oral formulation of Akynzeo(R) in China 2019-09-25 12:11
Supply Chain Digitization Creates New Revenue Opportunities in the Vaccine Market 2019-09-24 23:28
Global Pharmaceutical Functional and Multifunctional Excipients Industry to Cross the $10 Billion Mark by 2023 2019-09-24 22:45
FUJIFILM SonoSite Institute Now Available In Five Additional Languages 2019-09-24 21:00
PwC Health Research Institute Report Shows Social Determinants of Health Undermining Progress of Modern Medicine 2019-09-24 18:00
PolyU develops a new class of antibiotic candidates for fighting against superbugs 2019-09-24 17:46
The Web of Science Group Reveals Annual Citation Laureates of 'Nobel Class' 2019-09-24 15:00
Blue Sail Medical and Biosensors International enter the Structural Heart market with the acquisition of Switzerland based NVT AG. 2019-09-24 01:21
Over £1.7m Raised at Rolls-Royce 'Dine on the Line' - A Major Philanthropic Event in Support of Allergy Research at Evelina London 2019-09-23 22:28
CPhI recruiting freelance pharmaceutical authors contributing to the global industry professionals 2019-09-23 17:56
Saudi Ministry of Health: The Launch of "Ada'a Health" to Achieve Health Goals of the Saudi Vision 2030 2019-09-23 16:00
Number of Registered Users on Ping An Good Doctor Officially Exceeds 300 Million 2019-09-23 14:27
New Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care 2019-09-23 14:00
Menarini Silicon Biosystems to Host ESMO Symposium on Clinical Importance of Circulating Tumor Cells 2019-09-23 08:15
2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors 2019-09-22 14:22
2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab 2019-09-22 13:39
2019 CSCO | CStone releases preliminary results from the Phase Ia trial of CS1003 in Chinese patients with advanced tumors 2019-09-21 00:26
1 393 394 395 396 397 520